187 related articles for article (PubMed ID: 27460956)
1. Pheochromocytoma and paraganglioma in patients with neurofibromatosis type 1.
Gruber LM; Erickson D; Babovic-Vuksanovic D; Thompson GB; Young WF; Bancos I
Clin Endocrinol (Oxf); 2017 Jan; 86(1):141-149. PubMed ID: 27460956
[TBL] [Abstract][Full Text] [Related]
2. Pheochromocytoma and paraganglioma in cyanotic congenital heart disease.
Opotowsky AR; Moko LE; Ginns J; Rosenbaum M; Greutmann M; Aboulhosn J; Hageman A; Kim Y; Deng LX; Grewal J; Zaidi AN; Almansoori G; Oechslin E; Earing M; Landzberg MJ; Singh MN; Wu F; Vaidya A
J Clin Endocrinol Metab; 2015 Apr; 100(4):1325-34. PubMed ID: 25581599
[TBL] [Abstract][Full Text] [Related]
3. Clinical Predictors of Malignancy in Patients with Pheochromocytoma and Paraganglioma.
Dhir M; Li W; Hogg ME; Bartlett DL; Carty SE; McCoy KL; Challinor SM; Yip L
Ann Surg Oncol; 2017 Nov; 24(12):3624-3630. PubMed ID: 28884434
[TBL] [Abstract][Full Text] [Related]
4. A current review of the etiology, diagnosis, and treatment of pediatric pheochromocytoma and paraganglioma.
Waguespack SG; Rich T; Grubbs E; Ying AK; Perrier ND; Ayala-Ramirez M; Jimenez C
J Clin Endocrinol Metab; 2010 May; 95(5):2023-37. PubMed ID: 20215394
[TBL] [Abstract][Full Text] [Related]
5. Malignant pheochromocytoma and paraganglioma: a population level analysis of long-term survival over two decades.
Goffredo P; Sosa JA; Roman SA
J Surg Oncol; 2013 May; 107(6):659-64. PubMed ID: 23233320
[TBL] [Abstract][Full Text] [Related]
6. Pheochromocytomas are diagnosed incidentally and at older age in neurofibromatosis type 1.
Moramarco J; El Ghorayeb N; Dumas N; Nolet S; Boulanger L; Burnichon N; Lacroix A; Elhaffaf Z; Gimenez Roqueplo AP; Hamet P; Bourdeau I
Clin Endocrinol (Oxf); 2017 Mar; 86(3):332-339. PubMed ID: 27787920
[TBL] [Abstract][Full Text] [Related]
7. Interest of systematic screening of pheochromocytoma in patients with neurofibromatosis type 1.
Képénékian L; Mognetti T; Lifante JC; Giraudet AL; Houzard C; Pinson S; Borson-Chazot F; Combemale P
Eur J Endocrinol; 2016 Oct; 175(4):335-44. PubMed ID: 27450695
[TBL] [Abstract][Full Text] [Related]
8. Catecholamine metabolism in paraganglioma and pheochromocytoma: similar tumors in different sites?
Grouzmann E; Tschopp O; Triponez F; Matter M; Bilz S; Brändle M; Drechser T; Sigrist S; Zulewski H; Henzen C; Fischli S; Abid K
PLoS One; 2015; 10(5):e0125426. PubMed ID: 25946206
[TBL] [Abstract][Full Text] [Related]
9. Neurofibromatosis type 1 (NF1) and pheochromocytoma: prevalence, clinical and cardiovascular aspects.
Zinnamosca L; Petramala L; Cotesta D; Marinelli C; Schina M; Cianci R; Giustini S; Sciomer S; Anastasi E; Calvieri S; De Toma G; Letizia C
Arch Dermatol Res; 2011 Jul; 303(5):317-25. PubMed ID: 21042801
[TBL] [Abstract][Full Text] [Related]
10. Attention Deficit Hyperactivity Disorder in Pediatric Patients with Pheochromocytoma and Paraganglioma.
Batsis M; Dagalakis U; Stratakis CA; Prodanov T; Papadakis GZ; Adams K; Lodish M; Pacak K
Horm Metab Res; 2016 Aug; 48(8):509-13. PubMed ID: 27171833
[TBL] [Abstract][Full Text] [Related]
11. Clinical presentation of sporadic and hereditary pheochromocytoma/paraganglioma.
Lider Burciulescu SM; Randon C; Duprez F; Huvenne W; Creytens D; Claes KBM; de Putter R; T'Sjoen G; Badiu C; Lapauw B
Endocr Oncol; 2023 Jan; 3(1):e220040. PubMed ID: 37434651
[TBL] [Abstract][Full Text] [Related]
12. Is genetic screening indicated in apparently sporadic pheochromocytomas and paragangliomas?
Iacobone M; Schiavi F; Bottussi M; Taschin E; Bobisse S; Fassina A; Opocher G; Favia G
Surgery; 2011 Dec; 150(6):1194-201. PubMed ID: 22136840
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of the insulin-like growth factor 1 receptor (IGF-1R) is associated with malignancy in familial pheochromocytomas and paragangliomas.
Fernandez MC; Martin A; Venara M; Calcagno Mde L; Sansó G; Quintana S; Chemes HE; Barontini M; Pennisi PA
Clin Endocrinol (Oxf); 2013 Nov; 79(5):623-30. PubMed ID: 23506534
[TBL] [Abstract][Full Text] [Related]
14. Genetic testing in pheochromocytoma or functional paraganglioma.
Amar L; Bertherat J; Baudin E; Ajzenberg C; Bressac-de Paillerets B; Chabre O; Chamontin B; Delemer B; Giraud S; Murat A; Niccoli-Sire P; Richard S; Rohmer V; Sadoul JL; Strompf L; Schlumberger M; Bertagna X; Plouin PF; Jeunemaitre X; Gimenez-Roqueplo AP
J Clin Oncol; 2005 Dec; 23(34):8812-8. PubMed ID: 16314641
[TBL] [Abstract][Full Text] [Related]
15. Myocardial infarction in a 30-year-old patient with pheochromocytoma and type 1 neurofibromatosis.
Babińska A; Gnacińska A; Swiatkowska-Stodulska R; Sworczak K
Pol Arch Med Wewn; 2008 Sep; 118(9):517-23. PubMed ID: 18846988
[TBL] [Abstract][Full Text] [Related]
16. Composite Pheochromocytoma/Paraganglioma-Ganglioneuroma: A Clinicopathologic Study of Eight Cases with Analysis of Succinate Dehydrogenase.
Gupta S; Zhang J; Erickson LA
Endocr Pathol; 2017 Sep; 28(3):269-275. PubMed ID: 28752484
[TBL] [Abstract][Full Text] [Related]
17. Malignant Pheochromocytoma and Paraganglioma: 272 Patients Over 55 Years.
Hamidi O; Young WF; Iñiguez-Ariza NM; Kittah NE; Gruber L; Bancos C; Tamhane S; Bancos I
J Clin Endocrinol Metab; 2017 Sep; 102(9):3296-3305. PubMed ID: 28605453
[TBL] [Abstract][Full Text] [Related]
18. Clinical, Diagnostic, and Treatment Characteristics of
Jha A; de Luna K; Balili CA; Millo C; Paraiso CA; Ling A; Gonzales MK; Viana B; Alrezk R; Adams KT; Tena I; Chen A; Neuzil J; Raygada M; Kebebew E; Taieb D; O'Dorisio MS; O'Dorisio T; Civelek AC; Stratakis CA; Mercado-Asis L; Pacak K
Front Oncol; 2019; 9():53. PubMed ID: 30854332
[No Abstract] [Full Text] [Related]
19. Genotype-Phenotype Features of Germline Variants of the TMEM127 Pheochromocytoma Susceptibility Gene: A 10-Year Update.
Armaiz-Pena G; Flores SK; Cheng ZM; Zhang X; Esquivel E; Poullard N; Vaidyanathan A; Liu Q; Michalek J; Santillan-Gomez AA; Liss M; Ahmadi S; Katselnik D; Maldonado E; Salgado SA; Jimenez C; Fishbein L; Hamidi O; Else T; Lechan R; Tischler AS; Benn DE; Dwight T; Clifton-Bligh R; Sanso G; Barontini M; Vincent D; Aronin N; Biondi B; Koops M; Bowhay-Carnes E; Gimenez-Roqueplo AP; Alvarez-Eslava A; Bruder JM; Kitano M; Burnichon N; Ding Y; Dahia PLM
J Clin Endocrinol Metab; 2021 Jan; 106(1):e350-e364. PubMed ID: 33051659
[TBL] [Abstract][Full Text] [Related]
20. Emerging Treatments for Advanced/Metastatic Pheochromocytoma and Paraganglioma.
Ilanchezhian M; Jha A; Pacak K; Del Rivero J
Curr Treat Options Oncol; 2020 Aug; 21(11):85. PubMed ID: 32862332
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
